AbbVie supports disclosure and transparency on interactions between the healthcare industry and healthcare professionals to ensure public trust and confidence.
In alignment with the member companies of Medicines Australia, AbbVie has undertaken to be open and transparent when we provide a reportable payment to a healthcare professional or a third party as directed by a healthcare professional. Reportable payments or transfers of value are:
- Payments for the provision of services such as giving a lecture, chairing an educational meeting, providing advice as a member of an Advisory Board or as a Consultant
- Airfares, accommodation and/or conference registration fees to attend medical education or as part of the provision of services.
AbbVie has prepared the report for publication in accordance with the Medicines Australia Code of Conduct, Edition 19 and Australia’s Privacy legislation. The report identifies healthcare professionals by name where their consent has been provided. Where consent has not been provided, the information is reported in aggregate.
From 1 October 2016, reporting of these payments is mandatory.
The report is designed to be read on this website. It is also provided as a downloadable CSV file.
To comply with our privacy obligations, the report may be amended from time to time. The report here contains the most up to date information. Any use or disclosure of the data by a third party is the responsibility of that third party, who must comply with the Australian Privacy Act 1988.
For further information about the details in the report, please go to https://www.medicinesaustralia.com.au/code/transparency-reporting/payments-to-healthcare-professionals/.
This report will be available for at least three years from the date of publication.
- Reporting Period from 1 November 2018 onward